Kaye, D M. (20 December 2016). Transcatheter interatrial shunt device provides sustained clinical benefit at one year in patients with preserved or mildly reduced ejection fraction: The REDUCE LAP heart failure trial. Circulation, 134, . doi:10.1161/CIR.0000000000000472

"Transcatheter interatrial shunt device provides sustained clinical benefit at one year in patients with preserved or mildly reduced ejection fraction : The REDUCE LAP heart failure trial / David Kaye, Gerd Hasenfuß, Petr Neuzil, Marco Post, Rob Doughty, Jean-Noel Trochu, Adam Kolodziej, Ralf Westenfeld, Martin Penicka, Mark Rosenberg, Jörg Hausleiter, Philip Raake, Mark Petrie, Martin Bergmann, Guillaume Jondeau, Frank Silvestry, Chris Hayward" Circulation .

Kaye, David M. "Transcatheter Interatrial Shunt Device Provides Sustained Clinical Benefit At One Year in Patients With Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial." Circulation 134 (20 December 2016).